We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Ask ADVFN Intelligence (AI)
CEO Paul Romness available to meet with institutional investors OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates...
Funding expected to provide cash runway into 2026 98% of investment in private placement from Pre-IPO and/or IPO investors Data update from OST-HER2 Phase 2b clinical trial in recurrent...
Digital Marketing Campaign to Highlight Clinical-Stage Cancer Innovation OST-HER2 that activates cellular immunity against HER2+ cancer OS Therapies Joins the B2i Digital Featured Companies...
Funding will provide Company sufficient cash runway into 2026 95% of investment in private placement from Pre-IPO and/or IPO investors Data from OST-HER2 Phase 2b in recurrent, resected...
Topline Data from Phase 2b clinical trial of OST-HER2 in Osteosarcoma expected to be released in December 2024 OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.14 | -21.1111111111 | 5.4 | 5.93 | 3.95 | 60761 | 4.59232907 | CS |
| 4 | 2.39 | 127.807486631 | 1.87 | 6.48 | 1.8248 | 139027 | 4.06092694 | CS |
| 12 | 1.15 | 36.9774919614 | 3.11 | 6.48 | 1.58 | 59540 | 3.61931655 | CS |
| 26 | 0.26 | 6.5 | 4 | 6.48 | 1.58 | 124817 | 3.73000005 | CS |
| 52 | 0.26 | 6.5 | 4 | 6.48 | 1.58 | 124817 | 3.73000005 | CS |
| 156 | 0.26 | 6.5 | 4 | 6.48 | 1.58 | 124817 | 3.73000005 | CS |
| 260 | 0.26 | 6.5 | 4 | 6.48 | 1.58 | 124817 | 3.73000005 | CS |
| Symbol | Price | Vol. |
|---|---|---|
| SCPXScorpius Holdings Inc | US$ 0.54 (56.39%) | 90.87M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 29.82 (7.77%) | 70.98M |
| SPXSDirexion Daily S&P 500 Bear 3X Shares New | US$ 6.10 (-3.63%) | 60.02M |
| TSLZT Rex 2X Inverse Tesla Daily Target ETF | US$ 2.35 (-15.92%) | 58.82M |
| MSTUT Rex 2X Long MSTR Daily Target ETF | US$ 10.21 (25.43%) | 48.27M |
JPetroInc
3 months ago
JPetroInc
3 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
